Actively Recruiting
Ethanol Sclerotherapy Prior to ART
Led by Ankara University · Updated on 2024-10-16
84
Participants Needed
3
Research Sites
152 weeks
Total Duration
On this page
Sponsors
A
Ankara University
Lead Sponsor
H
Hacettepe University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to assess the impact of ethanol sclerotherapy on ART cycle outcomes. The main questions it aims to answer are: 1. Does ethanol sclerotherapy before ART cycle has any impact on cumulative live birth rate in patients with endometrioma? 2. Does ethanol sclerotherapy improve chronic pelvic pain, dysmenorrhea, complications during oocyte retrieval, response to ovarian stimulation (number of mature oocytes retrieved), and pregnancy loss rates? Infertile patients with endometrioma between 4-10 cm who are scheduled for ART within 2 cycles will be randomized to ethanol sclerotherapy or no intervention.
CONDITIONS
Official Title
Ethanol Sclerotherapy Prior to ART
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18 to 40 years
- Anti-mullerian hormone (AMH) level greater than 0.3 ng/ml
- Presence of unilateral or bilateral endometrioma
- Endometrioma cyst diameter between 40 and 100 mm
You will not qualify if you...
- History of three or more failed IVF or embryo transfer attempts
- Menstrual cycle abnormalities
- Male factor infertility
- Presence of uterine fibroids
- Presence of hydrosalpinx
- Presence of uterine abnormalities
- Suspicion of malignancy based on International Ovarian Tumor Analysis criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Başkent University Adana IVF Center
Adana, Turkey (Türkiye)
Actively Recruiting
2
Ankara University School of Medicine, Department of Obstetrics and Gynecology
Ankara, Turkey (Türkiye), 06610
Actively Recruiting
3
Bahçeci IVF Clinic
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
Y
Yavuz Emre Sukur
CONTACT
S
Sezcan Mumusoglu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here